Transverse vs Longitudinal Mucosal Incision During POEM

Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversidad Nacional de Colombia

About this trial

Peroral endoscopic myotomy (POEM) is a minimally invasive endoscopic procedure used to treat achalasia and other spastic esophageal motility disorders. A key step in POEM is creating a small opening in the esophageal lining (mucosal incision) to enter the submucosal tunnel. This study evaluates whether making that entry incision \*\*transverse\*\* (across the esophagus) versus \*\*longitudinal\*\* (along the esophagus) improves procedural efficiency without reducing safety.

This is a \*\*multicenter, randomized (1:1), parallel-group clinical trial\*\* conducted in three therapeutic endoscopy units in Colombia (Hospital Universitario del Valle and Clínica Versalles in Cali, and Clínica del Occidente in Bogotá). Adults (≥18 years) with an indication for POEM, ASA I-III, and ability to provide informed consent will be eligible; key exclusions include prior myotomy/major esophageal surgery, uncorrectable coagulopathy, pregnancy, active systemic infection, anesthesia contraindication, or anticipated technical inability to perform POEM.

All procedures are standardized: POEM under \*\*general anesthesia with orotracheal intubation\*\*, \*\*CO₂ insufflation\*\*, validated endoscopic knives and preset electrosurgical modes; hemostasis with \*\*Coagrasper® only if needed\*\*; and closure using standard \*\*through-the-scope (TTS) clips\*\*. Participants are randomly assigned to a \*\*15 mm transverse mucosal incision\*\* (perpendicular to the esophageal axis) or a \*\*15 mm longitudinal mucosal incision\*\*. Full-procedure video is recorded for quality control and to allow objective timing, with blinded assessment of the primary outcome.

The \*\*primary outcome\*\* is the time (seconds) from the first mucosal cut to successful entry of the endoscope cap into the submucosal tunnel (advancing at least 1 cm). \*\*Secondary outcomes\*\* include need for hemostasis with Coagrasper®, number of clips required for complete closure, and early complications (including perforation and gas-related events such as capnoperitoneum requiring decompression and emphysema), monitored through \*\*30 days\*\*.

Participants complete a screening/preoperative visit (up to 30 days before), undergo the POEM procedure, have early in-hospital/discharge assessment (days 1-2), and receive safety follow-up contacts at approximately 1 week and day 30.

Risks are those expected from standard POEM and peri-anesthesia care (e.g., bleeding, perforation, infection, and gas-related complications), and participants may not directly benefit clinically. However, the transverse incision may shorten access and closure time and reduce resource use without increasing short-term complications.

The study will be conducted with written informed consent, confidentiality protections (pseudonymization and secure storage), and reporting of results in aggregate form.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years

Diagnosis of achalasia or other spastic esophageal motility disorders with an indication for POEM

ASA physical status I-III

Ability to provide informed consent

Disqualifiers

Prior myotomy or major esophageal surgery

Uncorrectable coagulopathy

Pregnancy

Active systemic infection

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transverse Mucosal Incision During POEM

    Procedure/Surgery

    POEM performed with a 15 mm transverse mucosal incision (perpendicular to the esophageal axis) for entry into the submucosal tunnel, under a standardized POEM protocol (general anesthesia with orotracheal intubation, CO₂ insufflation, validated endoscopic knives/electrosurgical settings, hemostasis with Coagrasper® only if needed, and closure with TTS clips; full-procedure video recorded).

  • Longitudinal Mucosal Incision During POEM

    Procedure/Surgery

    POEM performed with a 15 mm longitudinal mucosal incision (parallel to the esophageal axis) for entry into the submucosal tunnel, under the same standardized POEM protocol (general anesthesia with orotracheal intubation, CO₂ insufflation, validated endoscopic knives/electrosurgical settings, hemostasis with Coagrasper® only if needed, and closure with TTS clips; full-procedure video recorded).

Treatment groups

140 Participants
are divided into 2 treatment groups
Group A: Transverse Mucosal Incision During POEMExperimental treatment 1 intervention
Group B: Longitudinal Mucosal Incision During POEMActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Time to Effective Submucosal Tunnel Entry (Seconds)

Time (in seconds) from the first mucosal cut to effective entry of the endoscope cap into the submucosal tunnel, defined as allowing advancement of at least 1 cm.

Time frame
During the POEM procedure (Day 0; intraoperative)

Secondary outcomes

1

Bleeding Requiring Hemostasis With Coagrasper®

Proportion of procedures with bleeding that requires hemostasis using Coagrasper® (Yes/No).

Time frame
During the POEM procedure (Day 0; intraoperative)
2

Procedure-Related Complications (Up to 30 Days)

Any complication related to the procedure, monitored through 30 days.

Time frame
Up to 30 days after the procedure (contacts at ~1 week and Day 30; plus early assessment Days 1-2).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Universidad Nacional de Colombia

Lead sponsor

Hospital San Rafael de Facatativá

Collaborator

This trial is not recruiting at the moment. You can still explore other options: